| 1 | [SID24811732] | Active | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24811732] | Active | Potency | 11.5774 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | Potency | 11.5774 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 3 | [SID24811732] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID24811732] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID24811732] | Active | Potency | 29.0929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | Potency | 29.0929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID24811732] | Active | | | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) [AID492992, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Confirmatory screen for identification of compounds that inhibit the two-pore domain potassium channel (KCNK9) | | AID | 492992 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 7 | [SID24811732] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 [AID488922, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 | | AID | 488922 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 8 | [SID24811732] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 9 | [SID24811732] | Active | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 10 | [SID24811732] | Active | | | Confirmation assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] [AID651638, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Confirmation assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] | | AID | 651638 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 11 | [SID24811732] | Active | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [AID602410, Type: screening] | Kcnk3 channel [Homo sapiens] [gi:11093520] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 | | AID | 602410 | | BioAssay type | screening | | Target | Kcnk3 channel [Homo sapiens] [gi:11093520] | | PubMed | | | Data Table |  |
|
| 12 | [SID24811732] | Active | | | Counter screen assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] in non-induced KCNK3 cells [AID651747, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Counter screen assay for identification of compounds that inhibit the two-pore domain potassium channel KCNK3 [Primary Screening] in non-induced KCNK3 cells | | AID | 651747 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID24811732] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 14 | [SID24811732] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 15 | [SID24811732] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID24811732] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 17 | [SID24811732] | Inactive | Potency | 0.3548 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | 0.3548 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 18 | [SID24811732] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 19 | [SID24811732] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 20 | [SID24811732] | Inactive | Potency | 100 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 21 | [SID24811732] | Inactive | | | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay [AID651999, Type: screening] | COPS5 gene product [Homo sapiens] [gi:38027923] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay | | AID | 651999 | | BioAssay type | screening | | Target | COPS5 gene product [Homo sapiens] [gi:38027923] | | PubMed | | | Data Table |  |
|
| 22 | [SID24811732] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. [AID2029, Type: screening] | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN. | | AID | 2029 | | BioAssay type | screening | | Target | citrate synthase 2 [Saccharomyces cerevisiae] [gi:171229] | | PubMed | | | Data Table |  |
|
| 23 | [SID24811732] | Inactive | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 24 | [SID24811732] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) [AID652017, Type: screening] | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM) | | AID | 652017 | | BioAssay type | screening | | Target | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, i [gi:119579215] | | PubMed | | | Data Table |  |
|
| 25 | [SID24811732] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 26 | [SID24811732] | Inactive | Potency | | qHTS Assay for Enhancers of SMN2 Splice Variant Expression [AID1458, Type: confirmatory] | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Enhancers of SMN2 Splice Variant Expression | | AID | 1458 | | BioAssay type | confirmatory | | Target | survival motor neuron protein isoform d [Homo sapiens] [gi:10937869] | | PubMed | | | Data Table |  |
|
| 27 | [SID24811732] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 28 | [SID24811732] | Inactive | Potency | | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID24811732] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 30 | [SID24811732] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels [AID2648, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels | | AID | 2648 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 31 | [SID24811732] | Inactive | Potency | | qHTS Assay for Modulators of Lamin A Splicing [AID1487, Type: confirmatory] | prelamin-A/C isoform 3 [Homo sapiens] [gi:27436948] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Modulators of Lamin A Splicing | | AID | 1487 | | BioAssay type | confirmatory | | Target | prelamin-A/C isoform 3 [Homo sapiens] [gi:27436948] | | PubMed | | | Data Table |  |
|
| 32 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 33 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 34 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 35 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 36 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 37 | [SID24811732] | Inactive | Potency | | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 38 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 39 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 40 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 41 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 42 | [SID24811732] | Inactive | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 43 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 44 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 45 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 46 | [SID24811732] | Inactive | Potency | | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. [AID1467, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. | | AID | 1467 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 47 | [SID24811732] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 48 | [SID24811732] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 49 | [SID24811732] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 50 | [SID24811732] | Inactive | Potency | | qHTS of GLP-1 Receptor Agonists [AID624172, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24811732 | | CID | 46497999 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Agonists | | AID | 624172 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|